Tratamento do tromboembolismo pulmonar maciço por fragmentação percutânea do trombo
| Autor: | Ricardo Pavanello, Leopoldo S. Piegas, Ibraim Maschiarelli Pinto, Enilton Egito, José Eduardo Moraes Rego Sousa, Barbosa Ma, Audrey Torres Barbosa, Dinaldo Cavalcanti de Oliveira, Antonio Massamitsu Kambara, Edson Romano |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Percutaneous Ventricular function business.industry Vascular access Systemic blood pressure medicine.disease Surgery Pulmonary embolism Internal medicine medicine.artery Pulmonary artery medicine Cardiology Thrombus Cardiology and Cardiovascular Medicine Prospective cohort study business |
| Zdroj: | Arquivos Brasileiros de Cardiologia. 88:279-284 |
| ISSN: | 0066-782X |
| Popis: | OBJECTIVES: To evaluate the safety and efficacy of percutaneous thrombus fragmentation (PTF) for massive pulmonary embolism (PE) in patients with contraindications to the administration of thrombolytics. METHODS: Between July 1999 and August 2005, 10 patients (7 males, 3 females, age 57±18 years) with massive PE and contraindications to the administration of thrombolytics underwent PTF. A transthoracic doppler echocardiogram was used to evaluate arterial oxygen saturation (Sat O2), the Walsh index (WI), mean pulmonary artery pressure (PAP), mean systemic blood pressure (SBP) and right ventricular function (RVF) before and after the procedure. Statistical analysis was conducted using the paired Wilcoxon test, of which p was significant when < 0.05. RESULTS: After the PTF treatment there was an improvement in Sat. O2 [87.4 ± 1.3% vs 92.3 ± 3.1% (p < 0.001)], WI [6.4 ± 1.07 vs 4.4 ± 1.42 (p = 0.003)], PAP [31.8 ± 4.6 mmHg vs 25.5 ± 3.4 mmHg (p < 0.001)] and SBP [73.9 ± 8.7 vs 85 ± 8.3 (p = 0.001). The ten patients had severe RVF before the percutaneous treatment; however, within 10 days after PTF, 8 presented normal or discrete function and 1 presented mitigated function. There were no technical or vascular access site complications related to PTF. One patient died in the hospital (10%). The procedure was successful for the other nine patients. CONCLUSION: The lack of adverse complications related to the procedure, proves that PTF is safe. The improvement in Sat O2, WI, PAP, SBP and RVF in 90% of the cases demonstrates the efficacy of the procedure, indicating that it is an alternative treatment for massive PE in patients with contraindications for the administration of systemic thrombolytics. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|